Enlivex Therapeutics Ltd

1BT

Company Profile

  • Business description

    Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

  • Contact

    14 Einstein Street
    Ness Ziona7403618
    ISR

    T: +972 26208072

    https://www.enlivex.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    36

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,770.6025.40-0.29%
CAC 407,678.3586.76-1.12%
DAX 4023,496.28275.17-1.16%
Dow JONES (US)42,451.37516.25-1.20%
FTSE 1008,841.2043.72-0.49%
HKSE23,892.56142.82-0.59%
NASDAQ19,498.81163.67-0.83%
Nikkei 22537,834.25338.84-0.89%
NZX 50 Index12,552.8796.23-0.76%
S&P 5006,002.6742.59-0.70%
S&P/ASX 2008,547.4017.70-0.21%
SSE Composite Index3,377.0025.66-0.75%

Market Movers